205 related articles for article (PubMed ID: 17337457)
1. Cost effectiveness analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery.
Rao C; Aziz O; Panesar SS; Jones C; Morris S; Darzi A; Athanasiou T
BMJ; 2007 Mar; 334(7594):621. PubMed ID: 17337457
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery.
Aziz O; Rao C; Panesar SS; Jones C; Morris S; Darzi A; Athanasiou T
BMJ; 2007 Mar; 334(7594):617. PubMed ID: 17337458
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
[TBL] [Abstract][Full Text] [Related]
5. A multi-centre randomised controlled trial of minimally invasive direct coronary bypass grafting versus percutaneous transluminal coronary angioplasty with stenting for proximal stenosis of the left anterior descending coronary artery.
Reeves BC; Angelini GD; Bryan AJ; Taylor FC; Cripps T; Spyt TJ; Samani NJ; Roberts JA; Jacklin P; Seehra HK; Culliford LA; Keenan DJ; Rowlands DJ; Clarke B; Stanbridge R; Foale R
Health Technol Assess; 2004 Apr; 8(16):1-43. PubMed ID: 15080865
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era.
Ariyaratne TV; Yap CH; Ademi Z; Rosenfeldt F; Duffy SJ; Billah B; Reid CM
Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):261-270. PubMed ID: 29474722
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study.
Griffin SC; Barber JA; Manca A; Sculpher MJ; Thompson SG; Buxton MJ; Hemingway H
BMJ; 2007 Mar; 334(7594):624. PubMed ID: 17339236
[TBL] [Abstract][Full Text] [Related]
8. Comparing cost aspects of coronary artery bypass graft surgery with coronary artery stenting.
Birim Ö; Bogers AJ; Kappetein AP
J Cardiovasc Surg (Torino); 2012 Oct; 53(5):641-50. PubMed ID: 22252542
[TBL] [Abstract][Full Text] [Related]
9. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease.
Yock CA; Boothroyd DB; Owens DK; Garber AM; Hlatky MA
Am J Med; 2003 Oct; 115(5):382-9. PubMed ID: 14553874
[TBL] [Abstract][Full Text] [Related]
11. One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial.
Weintraub WS; Mahoney EM; Zhang Z; Chu H; Hutton J; Buxton M; Booth J; Nugara F; Stables RH; Dooley P; Collinson J; Stuteville M; Delahunty N; Wright A; Flather MD; De Cock E
Heart; 2004 Jul; 90(7):782-8. PubMed ID: 15201249
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of on-pump and off-pump coronary artery bypass grafting for patients with coronary artery disease: Results from the MASS III trial.
Scudeler TL; Hueb WA; Farkouh ME; Maron DJ; de Soárez PC; Campolina AG; Takiuti ME; Rezende PC; Godoy LC; Hueb AC; Lima EG; Garzillo CL; Ramires JAF; Kalil Filho R
Int J Cardiol; 2018 Dec; 273():63-68. PubMed ID: 30158068
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of the clinical effectiveness and cost-effectiveness and economic modelling of minimal incision total hip replacement approaches in the management of arthritic disease of the hip.
de Verteuil R; Imamura M; Zhu S; Glazener C; Fraser C; Munro N; Hutchison J; Grant A; Coyle D; Coyle K; Vale L
Health Technol Assess; 2008 Jun; 12(26):iii-iv, ix-223. PubMed ID: 18513467
[TBL] [Abstract][Full Text] [Related]
14. Minimally invasive direct coronary artery bypass (MIDCAB) versus coronary artery stenting for elective revascularization of the left anterior descending artery.
Iakovou I; Dangas G; Mehran R; Lansky AJ; Stamou SC; Pfister AJ; Dullum MK; Leon MB; Corso PJ
Am J Cardiol; 2002 Oct; 90(8):885-7. PubMed ID: 12372581
[No Abstract] [Full Text] [Related]
15. Comparative economic analyses of minimally invasive direct coronary artery bypass surgery.
Gray DT; Veenstra DL
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):618-24. PubMed ID: 12658204
[TBL] [Abstract][Full Text] [Related]
16. Does previous percutaneous coronary stenting compromise the long-term efficacy of subsequent coronary artery bypass surgery? A microsimulation study.
Rao C; Stanbridge Rde L; Chikwe J; Pepper J; Skapinakis P; Aziz O; Darzi A; Athanasiou T
Ann Thorac Surg; 2008 Feb; 85(2):501-7. PubMed ID: 18222252
[TBL] [Abstract][Full Text] [Related]
17. Coronary bypass surgery versus percutaneous coronary intervention: cost-effectiveness in Iran: a study in patients with multivessel coronary artery disease.
Javanbakht M; Bakhsh RY; Mashayekhi A; Ghaderi H; Sadeghi M
Int J Technol Assess Health Care; 2014 Oct; 30(4):366-73. PubMed ID: 25401422
[TBL] [Abstract][Full Text] [Related]
18. Minimally invasive coronary artery bypass grafting decreases hospital stay and cost.
King RC; Reece TB; Hurst JL; Shockey KS; Tribble CG; Spotnitz WD; Kron IL
Ann Surg; 1997 Jun; 225(6):805-9; discussion 809-11. PubMed ID: 9230821
[TBL] [Abstract][Full Text] [Related]
19. Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
Eisenstein EL; Leon MB; Kandzari DE; Mauri L; Edwards R; Kong DF; Cowper PA; Anstrom KJ;
JACC Cardiovasc Interv; 2009 Dec; 2(12):1199-207. PubMed ID: 20129546
[TBL] [Abstract][Full Text] [Related]
20. Hybrid coronary revascularization in the era of drug-eluting stents.
Murphy GJ; Bryan AJ; Angelini GD
Ann Thorac Surg; 2004 Nov; 78(5):1861-7. PubMed ID: 15511503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
